Friedrich & ClementBETA

Molecular Biology Automation enabling an Extended Syndromic Approach

Automate de biologie moléculaire permettant une approche syndromique étendue

Belgium · Bruxelles (Auderghem) · how to bid here

Your path to submission

  1. Deadline: 29 September at 00:00 — 12 days left.
  2. The submission point is stated in the notice (link on the right).
  3. Offer and evidence in: FRA.
  4. Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Compiled automatically from notice and documents — no guarantee; the procedure's wording is binding.

Clement What the numbers say about this buyer

  • In this sector the buyer awards roughly every 2 months (32 awards, most recently February 2026) — by that rhythm the next award was due around May 2026. The last award went to X.Nov IP.n = 32
  • 6% of this buyer's awards went to companies that had already won here before (80 awards since 2015, spread over 42 companies). 94% went to new names.n = 80 awards since 2015
  • The median procedure drew 3 bids (58 procedures with a bid count); 9% ended with a single bidder. Sector: median 3 bids.n = 58
  • Across 6 procedures with structured selection criteria, this buyer most often required: Professional liability insurance (6 of 6), Minimum turnover in the contract field (4 of 6), Quality management (3 of 6), Quality control by institutes (3 of 6).n = 6
  • 28% of awards went to companies from abroad (80 awards with a known winner country). Sector average: 30%.n = 80

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 13/09/2026.

Clement
References and certificates from your home country count fully across the EU — that is what European procurement law is for.

Foreign bidders

In Belgium · Medical equipment & pharma, 424 contracts went to foreign companies over the last 3 years (of 2,320 recorded awards) — mostly from France, Netherlands, Germany.

Typical field: median 3 (from 28 awards).

Measured from linked award data; foreign winners bidding through a local subsidiary count as domestic — the true share is higher.

What the buyer is looking for

The summary in English is being prepared. The official description below is in the original language (DE).

Show original description (DE)

Automate de biologie moléculaire permettant une approche syndromique étendue

Description as published (DE).

Selection criteria — in the procurement documents

The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in FRA.

Contract

BuyerCHIREC
TypeSupplies
Estimated valuevalue not published
Published16 September 2026
CategoryMedical equipment & pharma · CPV 33100000

Who has won here before

CompanyAwardsPeriod
Teva Pharma Belgium22024–2025
Viatris BV22024
Jansen Finishings22015
ACCORD HEALTHCARE 22024
SANDOZ SA22024
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.

How often this buyer tenders this

20225
202419
202513
202616

Who knows the rhythm prepares instead of reacting.

·
days until the deadlineTuesday 29 September at 00:00

How to bid

Read the full noticeOriginal + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.

Tender documents — direct download

Specifications and annexes hosted by the buyer — usually accessible without registration.
Tenders like this, every morning at 7:30 in your inbox.
Register now →